Founder’s Expertise
Dr. Nathan Currier, the CEO and Founder of Currier Clinical Consulting, possesses over 25 years of experience in the clinical development, pre-clinical development, clinical research, and biotechnology sectors, including 10 years as an Oncology Strategy Lead in the clinical research organization (CRO) industry, with over 6 years at the largest CRO in the world. His PhD is in cellular and molecular biology from McGill University and he has spent the last 28 years focused in oncology.
Key experience
- PhD in cellular and molecular biology from McGill University, Montreal Canada
- 10 years of oncology Request for Proposal (RFP) experience, including protocol review
- Lead on over 400 oncology study RFPs and 130 BDMs for global companies of all sizes
- 25+ years of oncology background, leadership, and clinical study/site feasibility experience
- Lead on reviews of over 300 oncology protocols for global companies of all sizes
- Clinical site management experience at McGill University Health Centre in Montreal, Canada
With a robust background in oncology, clinical trial planning and strategy, study and site feasibility, and budget forecasting, Dr. Currier has successfully spearheaded over 400 oncology clinical trial studies through the RFP process and performed review of over 300 oncology protocols for biotechnology and biopharmaceutical firms across the globe. Under Dr. Currier’s leadership, Currier Clinical Consulting has developed a reputation for delivering strategic insights and innovative solutions tailored to the unique oncology clinical trial planning needs of small and medium companies. Dr. Currier’s expertise as an SME in navigating the complex, dynamic, global clinical trial landscape ensures that clients receive the highest level of guidance and support in oncology.
Meet and Connect with our President
Nathan Currier, PhD
CEO and Founder
Our Mission and Vision
Currier Clinical Consulting is committed to delivering unparalleled clinical consulting services to small and medium biotechnology and biopharmaceutical companies. Our mission is to empower these businesses with the insights and expertise they need to thrive in the competitive clinical trial landscape, with the critical success factor being the improvement of quality of life for patients with cancer. We envision a future where our clients lead the industry in innovation and success, supported by our dedicated partnership and strategic clinical consulting guidance.
Our Approach to Clinical Consulting
At Currier Clinical Consulting, our approach is rooted in a deep understanding of the biotechnology and biopharmaceutical industry and a true commitment to client-centric service. We leverage our insights and expertise in oncology research to provide customized solutions that address the unique challenges faced by small and medium companies in navigating the complex clinical landscape.
Our consulting process begins with a thorough assessment of your specific needs and objectives, assessing your wants and the relevance to the company’s goals, allowing us to tailor our services to align with their strategic goals. By fostering an environment of collaboration and open communication, we ensure that you and your team are equipped with the knowledge and resources necessary to achieve your desired outcomes.
Why Choose Us?
Choosing Currier Clinical Consulting means partnering with a team that is dedicated to your success. Our President, Dr. Nathan Currier, brings a wealth of experience and a multi-decade track record of excellence in oncology research and oncology clinical research. With a focus on innovation and strategic thinking, we are uniquely positioned to provide insights and solutions that drive growth and success for your company.
Our reputation is built on our ability to deliver results that exceed client expectations. By staying at the forefront of industry trends and maintaining a proactive approach to consulting, we help our clients navigate the complexities of the biotechnology sector with confidence. Trust us to be your reliable partner in strategic oncology clinical consulting.